Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
When they help prevent bleeding, blood clots are a normal and healthy function of the human body. However, a thrombosis (or thrombus) is an excessive or dangerous blood clot that develops somewhere it shouldn’t.
Thrombophilia refers to a group of disorders that increases a child’s tendency to develop excessive and dangerous blood clots, which can block blood supply to and damage organs and tissues. Thrombosis in children is uncommon, and is most often seen in children with complex medical problems.
The disorder can be thought of as the opposite of hemophilia, which prevents the blood from clotting.
How Dana-Farber/Boston Children's approaches blood clots
Children with abnormal blood clots are treated through our Thrombosis and Anticoagulation Program. At Dana-Farber/Boston Children's Cancer and Blood Disorders Center, we offer advanced treatment options for children with thrombosis and thrombophilia.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”